Enovid is a nasal spray, designed to prevent infection from all current versions of the SARS-CoV-2 virus by reducing the viral load within the respiratory tract. It delivers a measured dose of Nitric Oxide in each use. Phase 3 clinical trials showed that viral replication was suppressed within 24 hours of treatment.

Click here for the Enovid User Guide 

Enovid’s Nitric Oxide Nasal Spray (NONS) is the proprietary drug preparation from SaNOtize which was designed to kill the virus that causes COVID-19 in the upper airways, preventing it from incubating and spreading to the lungs by reducing the viral load in COVID-19 patients by more than 95%.

In controlled studies, all subsequent COVID-19 variants, including the latest omicron variants, show a reduction in viral load within 24 hours of treatment with Enovid VIRX. NONS contains a broad-spectrum antiviral that is effective in the lab against a wide range of viruses and so far, despite a large number of mutations of the coronavirus, this has not interfered with its effectiveness against viral replication.

Each bottle contains a month’s supply for one person to spray twice daily to protect against viruses.

How Enovid Works

Enovid is like a “hand sanitizer for the nose.” It creates a physical barrier in the nasal passages to stop viruses and delivers a “chemical barrier” of nitric oxide, known for its antimicrobial qualities.

Its ingredients are sodium chloride, citric acid, HPMC, sodium nitrite, and benzalkonium chloride. Most importantly, a small amount of nitric oxide is created when the spray is used. SaNOtize’s patented technology creates nitric oxide molecules only when needed.

When to use Enovid?

Enovid shields against respiratory viruses and should be administered before and after suspected exposure to SAR-CoV-2 virus, including omicron variants by individuals in high-risk environments or who have been exposed to other infected people, for example on public transportation, in health care settings, daycares, shopping centers, sports events, etc. 

Dosage

Enovid may be applied 2-3 times over the day in a normal environment or up to 5 times on one day immediately following suspected exposure to people who may be carrying the viruses. This is especially the case if coming into contact with COVID-19-infected people who have traveled to countries with high levels of infection. People at special risk, such as pregnant women, aged people, and people with compromised immune systems, can also safely use Enovid at higher dosages.

Storage

The spray can be used for 60 days after the first opening, or until the expiry date printed on the package, whichever comes first. The inhaler should be kept with the cap on, and at temperatures below 25ºC/77ºF